SNA insider plans Rule 144 sale of 3,831 shares on NYSE common stock

A stockholder of SNA has filed a Form 144 notice to sell 3,831 shares of common stock under Rule 144.

Rhea-AI Filing Summary

A stockholder of SNA has filed a Form 144 notice to sell 3,831 shares of common stock under Rule 144. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 11/25/2025 and an aggregate market value of $1,292,117.38. These shares were acquired on the same date by exercising stock options under a registered plan and paid for in cash.

The notice states that 52,007,557 common shares were outstanding, as reported in the form; this is a baseline figure, not the amount being sold. By signing, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SNA Form 144 filing disclose?

The filing discloses that a stockholder of SNA has notified the SEC of an intended Rule 144 sale of 3,831 shares of SNA common stock on the NYSE.

How many SNA shares are planned to be sold and at what value?

The notice covers the proposed sale of 3,831 common shares of SNA, with an aggregate market value of $1,292,117.38 as reported in the form.

When will the SNA Rule 144 sale take place and on which exchange?

The approximate sale date listed is 11/25/2025, and the shares are to be sold on the NYSE through a broker.

Which broker is handling the SNA Form 144 share sale?

The sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based in New York.

How were the SNA shares being sold under Form 144 acquired?

The 3,831 SNA common shares were acquired on 11/25/2025 via the exercise of options under a registered plan, with the purchase price paid in cash.

How many SNA shares were outstanding according to the Form 144 notice?

The notice reports that 52,007,557 common shares of SNA were outstanding. This figure provides context and is not the number of shares being sold.

Does the SNA Form 144 filing mention undisclosed adverse information?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/25/2025 - 04:38 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001775494
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SNAP-ON INCORPORATED
SEC File Number	001-07724
Address of Issuer	2801 80th Street Kenosha WISCONSIN 53143
Phone	(262) 656-5200
Name of Person for Whose Account the Securities are To Be Sold	JESUS MARIA ARREGUI SAEZ
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3831	1292117.38	52007557	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2025	Exercise of options under a registered plan	Issuer			3831	11/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jesus Maria Arregui
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)